Paper32130337
Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology.
Baddini-Martinez J and 21 others. J Bras Pneumol, 2020. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology. Papers, record 32130337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32130337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Idiopathic Pulmonary Fibrosis | Major topic |
| Practice Guidelines as Topic | Major topic |
| Acetylcysteine | |
| Aged | |
| Anti-Inflammatory Agents | |
| Brazil | |
| Humans | |
| Indoles | |
| Male | |
| Pyridones |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32402013 | Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone? | https://conductscience.org/library/papers/32402013 |
Source PubMed
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30578394 | Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis. | Eur Respir J | 2019 | https://conductscience.org/library/papers/30578394 | PubMed |
| 2 | 31365380 | Pulmonary hypertension due to interstitial lung disease. | Curr Opin Pulm Med | 2019 | https://conductscience.org/library/papers/31365380 | PubMed |
| 3 | 29341047 | German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017. | Pneumologie | 2018 | https://conductscience.org/library/papers/29341047 | PubMed |
| 4 | 28787186 | A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis. | Am J Respir Crit Care Med | 2018 | https://conductscience.org/library/papers/28787186 | PubMed |
| 5 | 31053121 | Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. | BMC Pulm Med | 2019 | https://conductscience.org/library/papers/31053121 | PubMed |
| 6 | 25806913 | Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25806913 | PubMed |
| 7 | 26400368 | Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis. | Respir Res | 2015 | https://conductscience.org/library/papers/26400368 | PubMed |
| 8 | 30610155 | Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis. | Thorax | 2019 | https://conductscience.org/library/papers/30610155 | PubMed |
| 9 | 23312392 | GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. | J Clin Epidemiol | 2013 | https://conductscience.org/library/papers/23312392 | PubMed |
| 10 | 22782597 | Highlights of the Brazilian Thoracic Association guidelines for interstitial lung diseases. | J Bras Pneumol | 2012 | https://conductscience.org/library/papers/22782597 | PubMed |
| 11 | 9847271 | Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. | Am J Respir Crit Care Med | 1998 | https://conductscience.org/library/papers/9847271 | PubMed |
| 12 | 29792287 | Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. | Lancet Respir Med | 2018 | https://conductscience.org/library/papers/29792287 | PubMed |
| 13 | 27876247 | Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. | Lancet Respir Med | 2017 | https://conductscience.org/library/papers/27876247 | PubMed |
| 14 | 25927225 | Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis. | BMC Pulm Med | 2015 | https://conductscience.org/library/papers/25927225 | PubMed |
| 15 | 22257422 | Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis. | Respirology | 2012 | https://conductscience.org/library/papers/22257422 | PubMed |
| 16 | 28257580 | A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly. | Am J Respir Cell Mol Biol | 2017 | https://conductscience.org/library/papers/28257580 | PubMed |
| 17 | 16306520 | High-dose acetylcysteine in idiopathic pulmonary fibrosis. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16306520 | PubMed |
| 18 | 26843176 | Treatment of idiopathic pulmonary fibrosis: a network meta-analysis. | BMC Med | 2016 | https://conductscience.org/library/papers/26843176 | PubMed |
| 19 | 26308723 | Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. | PLoS One | 2015 | https://conductscience.org/library/papers/26308723 | PubMed |
| 20 | 31365829 | Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE). | Am J Respir Crit Care Med | 2019 | https://conductscience.org/library/papers/31365829 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41297960 | Clinical care in interstitial lung disease: a critical appraisal of clinical guidance documents. | Eur Respir Rev | 2025 | https://conductscience.org/library/papers/41297960 | PubMed |
| 38965496 | Association between swallowing dynamics, tongue pressure and pulmonary function in patients with idiopathic pulmonary fibrosis. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/38965496 | PubMed |
| 38791861 | Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America. | Int J Environ Res Public Health | 2024 | https://conductscience.org/library/papers/38791861 | PubMed |
| 37909628 | Psychometric assessment of oral health-related quality of life questionnaires cross-culturally adapted for use in Brazilian adults - a systematic review. | Rev Bras Epidemiol | 2023 | https://conductscience.org/library/papers/37909628 | PubMed |
| 34495179 | Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification. | J Bras Pneumol | 2021 | https://conductscience.org/library/papers/34495179 | PubMed |
| 33503137 | Achievements of the last biennium, projections for the coming years, and the impact of COVID-19. | J Bras Pneumol | 2021 | https://conductscience.org/library/papers/33503137 | PubMed |
| 33313150 | Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/33313150 | PubMed |
| 32402013 | Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone? | J Bras Pneumol | 2020 | https://conductscience.org/library/papers/32402013 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EDN1 | 1906 | PubTator's text mining | https://conductscience.org/library/genes/1906 | NCBI Gene |
| PDE5A | 8654 | PubTator's text mining | https://conductscience.org/library/genes/8654 | NCBI Gene |
| SFTPD | 6441 | PubTator's text mining | https://conductscience.org/library/genes/6441 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TOLLIP | 54472 | PubTator's text mining | https://conductscience.org/library/genes/54472 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32130337
GET https://conductscience.org/api/papers/v1/32130337/authors?page=2